1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact being Reaffirmed or proceeding to Normative directly after being either Informative or STU?
No
1e. Today's Date
1f. Name of standard being reaffirmed
1g. Project Artifact Information
1h. ISO/IEC Standard to Adopt
1i. Does the standard include excerpted text from one or more ISO, IEC or ISO/IEC standards, but is not an identical or modified adoption?
1j. Unit of Measure
2a. Primary/Sponsor WG
Biomedical Research & Regulation
2d. Project Facilitator
Smita Hastak
2e. Other Interested Parties (and roles)
2f. Modeling Facilitator
Wendy Ver Hoef
2g. Publishing Facilitator
Myron Finseth
2h. Vocabulary Facilitator
Julie James
2i. Domain Expert Representative
HL7 BR&R Members, CDISC, NCI and FDA domain experts
2j. Business Requirements Analyst
2k. Conformance Facilitator
2l. Other Facilitators
2m. Implementers
3a. Project Scope
Changes are made to the BRIDG model based on work planned by FDA and NCI - we know there will be work, but at this point we are unclear what that will be. It will be similar in scope to that of previous releases. As an illustration BRIDG 5.3 was concerned with adding imaging semantics and updating a mapping; 5.2 was concerned with updates for anatomic pathology and specimen DAM modelling. The full release history is here: https://bridgmodel.nci.nih.gov/bridg-news#bridgrelease5.3.1. Any work of a greater scope than previously seen will be subject to separate approval.
Attachments
3b. Project Need
The BRIDG model is subject to an annual revision - this PSS covers the revision in 2020
3c. Security Risk
No
3d. External Drivers
3e. Objectives/Deliverables and Target Dates
Ballot for May 2020 ballot resolution
Publish Autumn 2020
3f. Common Names / Keywords / Aliases:
BRIDG, BRIDG Model, Biomedical Research Integrated Domain Group Model
3g. Lineage
New model version will replace previous model version.
3k. Additional Backwards Compatibility Information (if applicable)
3l. Using Current V3 Data Types?
Yes
3l. Reason for not using current V3 data types?
3m. External Vocabularies
3n. List of Vocabularies
3o. Earliest prior release and/or version to which the compatibility applies
BRIDG 5.3.1
4a. Products
Domain Analysis Model (DAM)
4b. For FHIR IGs and FHIR Profiles, what product version(s) will the profiles apply to?
4c. FHIR Profiles Version
4d. Please define your New Product Definition
4d. Please define your New Product Family
5a. Project Intent
Revise current standard
5a. White Paper Type
5a. Is the project adopting/endorsing an externally developed IG?
5a. Externally developed IG is to be (select one)
5a. Specify external organization
5a. Revising Current Standard Info
BRIDG 5.3.1
5b. Project Ballot Type
Informative
5c. Additional Ballot Info
5d. Joint Copyright
No
5e. I understand I must submit a Joint Copyright Letter of Agreement to the TSC in order for the PSS to receive TSC approval.
no
6a. External Project Collaboration
6b. Content Already Developed
6c. Content externally developed?
No
6d. List Developers of Externally Developed Content
6e. Is this a hosted (externally funded) project?
6f. Stakeholders
Regulatory Agency, Standards Development Organizations (SDOs)
6f. Other Stakeholders
6g. Vendors
Pharmaceutical, EHR, PHR, Health Care IT, Clinical Decision Support Systems, Lab, HIS, Other
6g. Other Vendors
Clinical Research Organisations
6h. Providers
6h. Other Providers
6i. Realm
Universal
7d. US Realm Approval Date
7a. Management Group(s) to Review PSS
7b. Sponsoring WG Approval Date
Oct 01, 2019
7c. Co-Sponsor Approval Date
7c. Co-Sponsor 2 Approval Date
7c. Co-Sponsor 3 Approval Date
7c. Co-Sponsor 4 Approval Date
7c. Co-Sponsor 5 Approval Date
7c. Co-Sponsor 6 Approval Date
7c. Co-Sponsor 7 Approval Date
7c. Co-Sponsor 8 Approval Date
7c. Co-Sponsor 9 Approval Date
7c. Co-Sponsor 10 Approval Date
7e. CDA MG Approval Date
7f. FMG Approval Date
7g. V2 MG Approval Date
7h. Architecture Review Board Approval Date
7i. Steering Division Approval Date
Oct 29, 2019
7j. TSC Approval Date
 Show Changes
Version
6
Modifier
Hugh Glover
Modify Date
Oct 03, 2019 11:29
1a. Project Name
BRIDG 2020 Update
1c. Is Your Project an Investigative Project (aka PSS-Lite)?
No
1d. Is your Project Artifact now proceeding to Normative directly or after being either Informative or STU?
No
2a. Primary/Sponsor WG
Biomedical Research & Regulation
2d. Project Facilitator
Smita Hastak
2f. Modeling Facilitator
Wendy Ver Hoef
2g. Publishing Facilitator
Myron Finseth
2h. Vocabulary Facilitator
Julie James
2i. Domain Expert Representative
HL7 BR&R Members, CDISC, NCI and FDA domain experts
3a. Project Scope
Changes are made to the BRIDG model based on work planned by FDA and NCI - we know there will be work, but at this point we are unclear what that will be.
3b. Project Need
The BRIDG model is subject to an annual revision - this PSS covers the revision in 2020
3c. Security Risk
No
3e. Objectives/Deliverables and Target Dates
Ballot for May 2020 ballot resolution
Publish Autumn 2020
3f. Common Names / Keywords / Aliases:
BRIDG, BRIDG Model, Biomedical Research Integrated Domain Group Model
3g. Lineage
New model version will replace previous model version.